share_log

There Is A Reason China Cyts Tours Holding Co., Ltd.'s (SHSE:600138) Price Is Undemanding

China Cyts Tours Holdingの株価がリーズナブルな理由がある

Simply Wall St ·  06/25 18:42

When close to half the companies in the Hospitality industry in China have price-to-sales ratios (or "P/S") above 4.5x, you may consider China Cyts Tours Holding Co., Ltd. (SHSE:600138) as a highly attractive investment with its 0.7x P/S ratio. Although, it's not wise to just take the P/S at face value as there may be an explanation why it's so limited.

ps-multiple-vs-industry
SHSE:600138 Price to Sales Ratio vs Industry June 25th 2024

What Does China Cyts Tours Holding's Recent Performance Look Like?

With revenue growth that's inferior to most other companies of late, China Cyts Tours Holding has been relatively sluggish. Perhaps the market is expecting the current trend of poor revenue growth to continue, which has kept the P/S suppressed. If this is the case, then existing shareholders will probably struggle to get excited about the future direction of the share price.

Keen to find out how analysts think China Cyts Tours Holding's future stacks up against the industry? In that case, our free report is a great place to start.

Is There Any Revenue Growth Forecasted For China Cyts Tours Holding?

In order to justify its P/S ratio, China Cyts Tours Holding would need to produce anemic growth that's substantially trailing the industry.

If we review the last year of revenue growth, the company posted a terrific increase of 48%. Pleasingly, revenue has also lifted 35% in aggregate from three years ago, thanks to the last 12 months of growth. So we can start by confirming that the company has done a great job of growing revenue over that time.

Turning to the outlook, the next year should generate growth of 16% as estimated by the eleven analysts watching the company. That's shaping up to be materially lower than the 28% growth forecast for the broader industry.

With this in consideration, its clear as to why China Cyts Tours Holding's P/S is falling short industry peers. Apparently many shareholders weren't comfortable holding on while the company is potentially eyeing a less prosperous future.

The Bottom Line On China Cyts Tours Holding's P/S

We'd say the price-to-sales ratio's power isn't primarily as a valuation instrument but rather to gauge current investor sentiment and future expectations.

As expected, our analysis of China Cyts Tours Holding's analyst forecasts confirms that the company's underwhelming revenue outlook is a major contributor to its low P/S. Right now shareholders are accepting the low P/S as they concede future revenue probably won't provide any pleasant surprises. The company will need a change of fortune to justify the P/S rising higher in the future.

You should always think about risks. Case in point, we've spotted 2 warning signs for China Cyts Tours Holding you should be aware of, and 1 of them shouldn't be ignored.

If strong companies turning a profit tickle your fancy, then you'll want to check out this free list of interesting companies that trade on a low P/E (but have proven they can grow earnings).

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする